Stuart McKechnie

Prof. Stuart McKechnie

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
YMYuxin Mi
Yuxin Mi
KBKatie L Burnham
Katie L Burnham
PCPhilip Charles
Philip Charles
RHRaphael Heilig
Raphael Heilig
IVIolanda Vendrell
Iolanda Vendrell
JKJulian C Knight
Julian C Knight
Sepsis, the dysregulated host response to infection causing life-threatening organ dysfunction, is a global health challenge requiring better understanding of pathophysiology and new therapeutic approaches. Here, we applied high-throughput tandem mass spectrometry to delineate the plasma proteome for sepsis and comparator groups (noninfected critical illness, postoperative inflammation, and healthy volunteers) involving 2612 samples (from 1611 patients) and 4553 liquid chromatography–mass spectrometry analyses acquired through a single batch of continuous measurements, with a throughput of 100 samples per day. We show how this scale of data can delineate proteins, pathways, and coexpression modules in sepsis and be integrated with paired leukocyte transcriptomic data (837 samples from n = 649 patients). We mapped the plasma proteomic landscape of the host response in sepsis, including changes over time, and identified features relating to etiology, clinical phenotypes (including organ failures), and severity. This work reveals subphenotypes informative for sepsis response state, disease processes, and outcome; identifies potential biomarkers; and advances opportunities for a precision medicine approach to sepsis.

1 February 2019 in Journal of Critical Care
Verified
Journal Article
Closed access
ASAkshay Shah
Akshay Shah
SFSheila A. Fisher
Sheila A. Fisher
HWHenna Wong
Henna Wong
NRNoémi B. Roy
Noémi B. Roy
SMStuart McKechnie
Stuart McKechnie
SSSimon J. Stanworth
Simon J. Stanworth

19 July 2013 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
JFJez Fabes
Jez Fabes
GBGraham Barker
Graham Barker
GSGemma Simons
Gemma Simons
NCNicola Curry
Nicola Curry
SBSusan J Brunskill
Susan J Brunskill
SSSimon Stanworth
Simon Stanworth

23 March 2022 in medRxiv
Verified
Preprint
Open access
PDF file
AKAndrew J. Kwok
Andrew J. Kwok
AAAlice Allcock
Alice Allcock
RFRicardo C. Ferreira
Ricardo C. Ferreira
MSMadeleine Smee
Madeleine Smee
ECEddie Cano-Gamez
Eddie Cano-Gamez
JKJulian C. Knight
Julian C. Knight
Sepsis is a condition of high mortality arising from dysregulation of the host immune response. Gene expression studies have identified multiple immune endotypes but gaps remain in our understanding of the underlying biology and heterogeneity. We used single-cell multi-omics to profile 272,993 cells across 48 whole blood samples from 26 sepsis patients (9 with paired convalescent samples), 6 healthy controls and 7 post-surgery patients. We identified immature neutrophil populations specific to sepsis and demonstrated the immunosuppressive nature of sepsis neutrophils in vitro. An IL1R2 + neutrophil state was expanded in a transcriptomic sepsis endotype associated with increased early mortality (sepsis response signature 1, SRS1), together with enrichment of the response to IL-1 pathway in mature neutrophils, marking IL-1 out as a potential target for immunotherapy in SRS1 sepsis patients. We confirmed the expansion of immature neutrophils, specifically IL1R2+ neutrophils, in SRS1 in additional cohorts of patients (n = 906 RNA-sequencing samples, n = 41 CyTOF samples). Neutrophil changes persisted in convalescence, implicating disrupted granulopoiesis. Our findings establish a cellular immunological basis for transcriptomically defined sepsis endotypes and emphasise the relevance of granulopoietic dysfunction in sepsis, identifying opportunities for precision medicine approaches to the condition.

9 August 2022 in medRxiv
Verified
Preprint
Open access
PDF file
YMYuxin Mi
Yuxin Mi
KBKatie L Burnham
Katie L Burnham
PCPhilip Charles
Philip Charles
RHRaphael Heilig
Raphael Heilig
IVIolanda Vendrell
Iolanda Vendrell
JKJulian C Knight
Julian C Knight
Summary: Sepsis, the dysregulated host response to infection causing life-threatening organ dysfunction, is an unmet global health challenge. Here we apply high-throughput tandem mass spectrometry to delineate the plasma proteome for sepsis and comparator groups (non-infected critical illness, post-operative inflammation and healthy volunteers) involving 2622 samples and 4553 liquid chromatography-mass spectrometry analyses in a single batch, at 100 samples/day. We show how this scale of data can establish shared and specific proteins, pathways and co-expression modules in sepsis, and be integrated with paired leukocyte transcriptomic data (n=837 samples) using matrix decomposition. We map the landscape of the host response in sepsis including changes over time, and identify features relating to etiology, clinical phenotypes and severity. This work reveals novel subphenotypes informative for sepsis response state, disease processes and outcome, highlights potential biomarkers, pathways and processes for drug targets, and advances a systems-based precision medicine approach to sepsis.

Verified
Journal Article
Open access
PDF file
RTRosie Taylor
Rosie Taylor
SVSarah A. Vollam
Sarah A. Vollam
SMStuart McKechnie
Stuart McKechnie
ASAkshay Shah
Akshay Shah
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. The number of patients with sepsis requiring critical care admission is increasing. At the same time, overall mortality from sepsis is declining. With increasing survival to hospital discharge, there are an increasing number of sepsis survivors whose care needs shift from the acute to chronic care settings. Recently, the phrase “post-sepsis syndrome” has emerged to encompass the myriad of complications in patients recovering from sepsis. The aim of this narrative review is to provide a contemporary summary of the available literature on post-sepsis care and highlight areas of ongoing research. There are many incentives for improving the quality of survivorship following sepsis, including individual health-related outcomes (e.g., increased survival, enhanced physical and psychological health) and wider socio-economic benefits (e.g., reduced economic burden on the healthcare systems, reduced physical and psychological burden on carers, ability for individuals (and carers) to return to workforce). Modifiable factors influencing long-term outcomes can be in-hospital or after discharge, when primary care physicians play a pivotal role. Despite national and international guidance being available, this area has been under-recognised historically, despite its profoundly negative impact on both patients and their families or caregivers. Contributing factors likely include the lack of a formally recognised “disease” or pathology, the presence of challenging-to-treat symptoms such as fatigue, weakness and cognitive impairment, and the prevailing assumption that ongoing rehabilitation merely requires time. Our review will focus on the following areas: screening for new cognitive and physical impairments; optimisation of pre-existing comorbidities; transition to primary care; and palliative care. Primary care physicians may have a crucial role to play in improving outcomes in sepsis survivors, and candidate interventions include education on common complications of post-sepsis syndrome.